Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Identification of the Conjugative mefGene in Clinical Acinetobacter junii and Neisseria gonorrhoeae Isolates

Vicki A. Luna, Sydney Cousin Jr., William L. H. Whittington, Marilyn C. Roberts
Vicki A. Luna
Departments of Pathobiology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sydney Cousin Jr.
Departments of Pathobiology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William L. H. Whittington
Medicine, University of Washington, Seattle, Washington 98195
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marilyn C. Roberts
Departments of Pathobiology and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.44.9.2503-2506.2000
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

The mef gene, originally described for gram-positive organisms and coding for an efflux pump, has been identified in clinical isolates of Acinetobacter junii andNeisseria gonorrhoeae. These strains could transfer themef gene at frequencies ranging from 10−6 to 10−9 into one or more of the following recipients: gram-negative Moraxella catarrhalis, Neisseria perflava/sicca and Neisseria mucosa and gram-positiveEnterococcus faecalis. Three Streptococcus pneumoniae strains could transfer the mef gene intoEikenella corrodens, Haemophilus influenzae,Kingella denitrificans, M. catarrhalis,Neisseria meningitidis, N. perflava/sicca, andN. mucosa at similar frequencies. The mef gene can thus be transferred to and expressed in a variety of gram-negative recipients.

The mef gene encodes a membrane-bound efflux protein and confers resistance to macrolides but not to lincosamides or streptogramin B (24, 25). From geographically diverse areas, two gene variants with 90% nucleotide sequence identity, mefA and mefE, have been identified in gram-positive organisms, including Streptococcus pneumoniae, Streptococcus pyogenes,Corynebacterium spp., Enterococcus spp.,Micrococcus luteus, and viridans group streptococci (2, 5, 9, 20, 23-25). Both genes have now been combined asmef(A) (20).

Recently, we have shown that both Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes (20). However, we have also identified several of these Neisseria spp. and oral gram-negative isolates that were macrolide resistant yet did not carry Erm determinants (ErmA, -B, -C, or -F) (21). We selected a gram-negativeAcinetobacter junii strain and screened two groups ofN. gonorrhoeae in order to determine if the mefgene was present. Because we have shown that the mef gene can be transferred by conjugation in various gram-positive genera, we also wanted to determine the mobility of the mef gene in these gram-negative isolates as well as the ability of gram-positive donors to move the mef gene to gram-negative species (9).

(This work was presented, in part, at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, 23 to 27 September 1999, San Francisco, Calif.)

MATERIALS AND METHODS

Bacteria.Erythromycin-resistant (Eryr)Acinetobacter junii strain 329 was isolated from the oral gumline of a child in Portugal (Table 1). The organism was identified by D. Stroman (Alcon Laboratories, Inc., Fort Worth, Tex.) by sequencing the 16S rRNA. Sixteen N. gonorrhoeae isolates with variable susceptibilities to erythromycin (MIC = 0.25 to 4 μg/ml) were collected from urethral specimens from adults in Seattle, Wash., and identified by theNeisseria Reference Laboratory at the University of Washington (Table 1). Thirteen N. gonorrhoeae isolates carrying the tetM 25.2-MDa plasmid were collected in Seattle and the eastern United States during 1983 through 1986 and have been previously described (7). Of the three EryrS. pneumoniae strains carrying the mef gene, two (n011 and 970146) were isolated in Washington State and the third (02J1048) was supplied by Pfizer Inc. (Groton, Conn.) (Table 1) (9, 26). Strains used as recipients are listed in Table2. Antibiotic susceptibilities were determined using either disk diffusion or agar dilution as described by the NCCLS (13).

View this table:
  • View inline
  • View popup
Table 1.

Isolates carrying the mef gene

View this table:
  • View inline
  • View popup
Table 2.

Characterization of recipients used

Media. S. pneumoniae isolates were grown on brucella blood agar (Difco, Detroit, Mich.) supplemented with 5% sheep red blood cells and incubated with 5% CO2 at 36.5°C (8). The Haemophilus influenzae isolate was grown on brain heart infusion (BHI) agar (Difco) supplemented with 2 μg of NAD (Sigma Chemical Co., St. Louis, Mo.) per ml and 10 μg of hemin–l-histidine (Sigma Chemical Co.) per ml (16). Eikenella corrodens, Kingella denitrificans, Moraxella catarrhalis, N. gonorrhoeae, Neisseria meningitidis, Neisseria perflava/sicca, and Neisseria mucosa were grown on gonococcus (GC) medium agar (Difco) supplemented with Kellogg's supplement solution (0.22 M d-glucose, 0.03 Ml-glutamine, 0.001 M ferric nitrate, and 0.02 M cocarboxylase) (Sigma-Aldrich Chemical Co., St. Louis, Mo.) as previously described (6, 15). Enterococcus faecalis JH2-2 was grown on BHI agar without supplements (9). For DNA dot blots and DNA extractions, the gram-positive bacteria were grown overnight at 36.5°C in BHI broth (Difco) supplemented with 0.03 M d-glucose and 0.04%dl-threonine (8, 9). The gram-negative bacteria, for DNA dot blots and DNA extractions, were grown in either BHI broth with no supplements (A. junii), BHI broth supplemented with 2 μg of NAD per ml and 10 μg of hemin–l-histidine per ml (H. influenzae), or GC broth supplemented with 1% sodium bicarbonate and Kellogg's supplement (see above) (E. corrodens, K. denitrificans, M. catarrhalis, and Neisseria spp.) as described previously (11, 12, 15).

Mating procedure.Donor and recipient bacteria were grown separately at 36.5°C overnight. Each isolate was suspended in 0.5 to 1.0 ml of BHI or GC broth (Difco) to a density of approximately 109 cells per ml (3 McFarland). Donor and recipient bacteria at ratios of 1:20 or 1:40 (donor to recipient) were mixed. The bacterial suspension was then plated directly onto brucella blood agar plates and incubated in CO2 at 36.5°C for 48 h (8, 9). After incubation, the mating mixture was serially diluted onto antibiotic-supplemented plates as follows: for H. influenzae recipients, erythromycin (10 μg/ml) and rifampin (10 μg/ml); for E. faecalis recipients, erythromycin (10 μg/ml) and rifampin (10 μg/ml); for M. catarrhalis,N. gonorrhoeae, and N. meningitidis recipients, erythromycin (2 μg/ml) and rifampin (10 μg/ml); and for E. corrodens, K. denitrificans, N. perflava/sicca, and N. mucosa recipients, erythromycin (2 μg/ml) and tetracycline (10 μg/ml). Gram stains were prepared from all transconjugants, and all transconjugants were identified to species level by established methods (4, 14). Mating experiments were performed a minimum of two times. DNase I (1 mg/ml) (Sigma-Aldrich Chemical Co.) was added to the mating mixture in at least one of the two matings for comparison with mating without DNase to rule out transformation.

Extraction of whole-cell DNA.Whole-cell DNA was prepared from isolates and transconjugants as previously described (1, 8). DNA was separated on a 0.7% agarose gel and Southern blots were prepared (22).

Plasmid analysis of transconjugants.Plasmid extractions were prepared from K. denitrificans, N. perflava/sicca, and their respective transconjugants after 8 h of growth in 40 ml of GC peptone broth supplemented with Kellogg's supplement solution and 1% sodium bicarbonate as previously described (3, 15). DNA was separated on a 0.7% agarose gel in 0.5× Tris-borate-EDTA (TBE) buffer at 100 V for 1.5 h; Southern blots were prepared and hybridized with mef-specific32P-labeled oligonucleotide probe MF5 to examine the location of the mef gene.

Dot blots.Two milliliters of overnight bacterial growth in supplemented BHI or GC broth was placed into 1.5-ml sterile Eppendorf tubes and centrifuged at 8,000 × g for 2 min, and the supernatant was decanted. The bacterial pellet was resuspended with 1 ml of BHI broth to create a turbid suspension of 3 McFarland. Two hundred microliters of the suspension, in 25-μl aliquots, was spotted onto a GeneScreen Plus membrane (NEN Research, Boston, Mass.), dried, and treated with 0.5 M NaOH for 10 min, 1 M Tris-HCl for 3 min, and 1 M Tris-HCl with 1.5% NaCl, pH 7.5, for 10 min. The membrane was dried, washed in chloroform-isoamyl alcohol (24:1), rinsed in water twice, washed in 1 M Tris-HCl with 1.5% NaCl for 10 min, and baked at 80°C for 1 h. The filters were stored at room temperature until hybridized with labeled oligonucleotide probes (8).

Labeled probes.MF5 (5′ GGT GCT GTG ATT GCA TCT ATT AC 3′) was used as the oligonucleotide probe for the mef gene (9). The oligonucleotide probes for the erm genes were the following: ermBF (5′ GAA AAG GTA CTC AAC CAA ATA 3′), ermCR (5′ GCT AAT ATT GTT TAA ATC GTC AAT 3′), and ermF1 (5′ CGG GTC AGC ACT TTA CTA TTG 3′) (19). A32P-labeled probe was used for whole-bacterial-cell dots as previously described (9).

PCR.PCR amplification used 40 ng of genomic DNA fromS. pneumoniae 02J1048 as a positive control and 30 ng of genomic DNA as a template from the transconjugants and A. junii. Primers were MF4a (5′ ACC GAT TCT ATC AGC AAA G 3′) and MF6 (5′ GGA CCT GCC ATT GGT GTG 3′). Both primers are in the conserved regions of the mef gene. Each reaction mixture contained 2 U of Taq polymerase (Perkin-Elmer Cetus, Norwalk, Conn.), 200 μM deoxynucleoside triphosphates, 1× PCR buffer (1.5 mM MgCl2), and 100 ng of each primer. Using a Perkin-Elmer Cetus thermal cycler, the reactions were carried out by denaturation at 94°C for 1 min, annealing at 37°C for 1 min, and elongation at 72°C for 2 min, for 35 cycles. The PCR products were dried, resuspended in 1/10 volume of sterile water, and separated on a 1.5% agarose gel with 0.5× TBE running buffer. The PCR bands were visualized by ethidium bromide staining, and Southern blots were prepared. The 940-bp PCR product hybridized with a labeled internalmef probe, MF5 (9). Positive and negative controls were run with each assay.

DNA-DNA hybridization.Southern blots using uncut whole-cell DNA or the PCR fragments were prepared on Magnagraph nylon (Micron Separation Inc., Westboro, Mass.) and hybridized with32P-labeled oligonucleotide MF5. DNA dot blots containing 30 to 300 μg of extracted whole-cell DNA from the donor strains and bacterial dot blots from transconjugants were placed on GeneScreen Plus membranes and hybridized with the radiolabeled oligonucleotide probe (8, 9).

Sequencing.Sequencing of selected isolates (A. junii 329 and N. gonorrhoeae 98.420 and 98.737) was performed using oligonucleotide primers MF7 (5′ ATG CAG ACC AAA AGC GCG AT 3′) and MF8 (5′ CGG TAT CTG TTC TGG TAG CG 3′). Both primers are in the conserved regions of the mef gene and within the generated PCR fragment. Each reaction mixture contained 2 U ofTaq polymerase, 200 μM deoxynucleoside triphosphates, 1× PCR buffer (1.5 mM MgCl2), and 100 ng of each primer. Using a Perkin-Elmer Cetus thermal cycler, the reactions were carried out by denaturation at 94°C for 1 min, annealing at 51°C for 1 min, and elongation at 72°C for 2 min, for 35 cycles. The PCR products were filtered by centrifugation with a 0.5-μm-pore-size separation filter (Micron) by following the manufacturer's directions. A small part of the PCR product obtained was dried and separated on a 1.5% agarose gel with 0.5× TBE running buffer. The 253-bp PCR product was then visualized by ethidium bromide staining. The remainder of the PCR product was then sequenced by following the Big Dye Terminator chemistry protocol (Perkin-Elmer Cetus, Foster City, Calif.). The sequence reaction mixture included 100 ng of the PCR product and 4 pmol of primer MF7, with a total volume of 12 μl. The mefsequence was compared to the mef sequence from S. pneumoniae (GenBank number U83667) using the Genetics Computer Group software (University of Wisconsin, Madison).

RESULTS

The mef gene in gram-negative bacteria.We examined 29 N. gonorrhoeae isolates for the presence of themef gene using DNA-DNA hybridization of bacterial dot blots. Four (14%) were positive and verified as carrying the mefgene by hybridization of Southern blots and positive PCR assays. Three of the mef-positive isolates were from Seattle and one was from Georgia. The mef gene was also identified by the same means in an oral A. junii isolate from Portugal. The PCR fragments were sequenced from the A. junii isolate and from two of the N. gonorrhoeae isolates. The first 9 nucleotides of the PCR product could not be adequately sequenced; however, the three isolates had 97 to 98% nucleotide identity with the GenBank sequence of the pneumococcal mef gene over the remaining 244 nucleotides and had 98% amino acid identity over 81 amino acids.

All four N. gonorrhoeae isolates carried the gonococcal 2.6-MDa plasmid, and strain 85.022462 carried a 25.2-MDa plasmid as well. When the mef probe was hybridized with Southern blots containing both chromosomal and plasmid DNA, only the chromosomal band hybridized in all four isolates. The A. junii isolate had no visible plasmids, and the mef probe hybridized with the chromosomal band in this isolate (data not shown).

We examined the five isolates for the presence of erm genes, which code for rRNA methylase genes (20). Of the fourNeisseria isolates, 98.420 and 85.022462 hybridized with probes for erm(B) and erm(F) while 98.560 hybridized with the probes for erm(B) and erm(C).N. gonorrhoeae 98.737 and A. junii 329 did not hybridize with any of the erm probes examined (Table 1). In addition, A. junii 329 was susceptible to clindamycin, suggesting that this isolate did not carry an Erm determinant.

In mixed cultures, we were able to transfer the mef gene from A. junii 329 and N. gonorrhoeae 98.737 toE. faecalis at frequencies of 10−6 and 10−9 per donor cell, respectively, and to M. catarrhalis and N. mucosa at a frequency of 10−8 per donor cell (Table3). We were able to transfer themef gene by conjugation from A. junii to N. perflava/sicca at a frequency of 10−9 per donor cell (Table 3). DNA-DNA hybridization of bacterial dot and Southern blots of cellular DNA and amplification of PCR products confirmed the presence of the mef gene in transconjugants. The recipients did not carry plasmids and the mef gene probe hybridized with the chromosomal band in these transconjugants, although the presence of very large plasmids could not be ruled out. The transconjugants grew on media supplemented with 2 to 10 μg of erythromycin per ml, depending upon the recipient, whereas the original recipients did not grow on media supplemented with erythromycin. This corresponds to a six- to eightfold increase in MICs (0.03 μg/ml versus 2 to 10 μg/ml). All of the transconjugants remained susceptible to clindamycin. As in our previous work, no other antibiotic resistance determinants were transferred with the mef gene.

View this table:
  • View inline
  • View popup
Table 3.

Conjugal transfer of themef genea

Conjugation of the S. pneumoniae mef gene with gram-negative bacteria.To examine whether gram-positive S. pneumoniae could transfer mef to gram-negative recipients, we used three pneumococcal donors and obtained frequencies of transfer of mef to E. corrodens, H. influenzae, K. denitrificans, M. catarrhalis, N. meningitidis, N. mucosa, andN. perflava/sicca that were similar those obtained withA. junii as the donor (Table 3). Although the K. denitrificans and E. corrodens transconjugants carried the 25.2-MDa tetM plasmid, the mef probe hybridized with the chromosomal region but not with the 25.2-MDa plasmid.

DISCUSSION

This is the first time the mef gene has been identified in clinical gram-negative isolates. These isolates were collected over a 13-year time span and from different geographical areas and ecological niches (oral and genital). We showed that these isolates transfer the mef gene to both gram-negative and gram-positive recipients (Table 3). In all cases, the mefgene appeared to be localized to the chromosome rather than to indigenous plasmids, although plasmids larger than 25.2 MDa cannot entirely be ruled out. Previous work with the mef gene in gram-positive donors and recipients has demonstrated not a specific location in the chromosome but potentially multiple random sites (9, 10). We are currently examining whether this is also true with the gram-negative recipients used in this study. However, we did not find the mef gene inserted into the 25.2-MDa plasmid. The mef sequence in the A. junii andN. gonorrhoeae isolates had 97 to 98% nucleotide identity to the mef gene found in S. pneumoniae, suggesting that these genes originally came from a gram-positive donor. A similar picture has emerged for the tetM, tetO, and erm genes found in the gram-negative flora (18-21).

To examine whether the mef genes located in S. pneumoniae could be transferred into gram-negative recipients, we examined three randomly chosen isolates and documented their ability to transfer mef into a variety of different oral recipient species (Table 3). Our data suggest that the mef gene host range may extend to a larger number of species and genera than theAcinetobacter and Neisseria organisms in this study. A survey of a variety of gram-negative species and genera from different ecological niches and locations should be done to better define the host range of the mef gene and its potential impact on macrolide therapy.

ACKNOWLEDGMENTS

The study was supported in part by NIH grants U01-DE-1189 and AJ-131448 and contract N01-DE-72623. V. Luna was supported in part by Oral Biology Training Grant T-32-DE-07063, and S. Cousin was supported by the Poncin Research Award Scholarship Fund.

We gratefully acknowledge the valuable technical assistance of Karen Winterscheid, Maria Strejac, and Kathleen Judge.

FOOTNOTES

    • Received 28 December 1999.
    • Returned for modification 28 March 2000.
    • Accepted 1 June 2000.
  • Copyright © 2000 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Anderson D. G.,
    2. McKay L. L.
    Simple and rapid method for isolating large plasmid DNA from lactic streptococci. Appl. Environ. Microbiol. 46 1983 549 552
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Clancy J.,
    2. Petitpas J.,
    3. Dib-Hajj F.,
    4. Yuan W.,
    5. Cronan M.,
    6. Kamath A.,
    7. Bergeron J.,
    8. Retsema J.
    Molecular cloning and functional analysis of a novel macrolide-resistance determinant mefA from Streptococcus pyogenes. Mol. Microbiol. 22 1996 867 879
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Elwell L. P.,
    2. Roberts M.,
    3. Mayer L. W.,
    4. Falkow S.
    Plasmid-mediated beta-lactamase production in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 11 1977 528 533
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Facklam R. R.,
    2. Sahm F.
    Enterococcus Manual of clinical microbiology 6th ed. Murray P. R., Baron E. J., Pfaller M. A., Tenover F. C., Yolken R. H. 1995 308 314 American Society for Microbiology Washington, D.C.
  5. 5.↵
    1. Kataja J.,
    2. Huovinen P.,
    3. Skurnik M.,
    4. The Finnish Study Group for Antimicrobial Resistance,
    5. Seppälä H.
    Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43 1999 48 52
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Knapp J. S.,
    2. Johnson S. R.,
    3. Zenilman J. M.,
    4. Roberts M. C.,
    5. Morse S. A.
    High-level tetracycline resistance resulting from TetM in strains of Neisseria spp., Kingella denitrificans, and Eikenella corrodens. Antimicrob. Agents Chemother. 32 1988 765 767
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Knapp J. S.,
    2. Zeilina J. M.,
    3. Biddle J. W.,
    4. Perkins G. H.,
    5. DeWitt W. D.,
    6. Thomas M. L.,
    7. Johnson S. R.,
    8. Morse S. A.
    Frequency and distribution in the United States of strains of N. gonorrhoeae with plasmid-mediated high-level resistance to tetracycline. J. Infect. Dis. 155 1988 819 822
    OpenUrl
  8. 8.↵
    1. Luna V. A.,
    2. Roberts M. C.
    The presence of the tetO gene in a variety of tetracycline resistant Streptococcus pneumoniae serotypes from Washington State. J. Antimicrob. Chemother. 42 1998 613 619
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Luna V. A.,
    2. Coates P.,
    3. Cove J. H.,
    4. Eady A. E.,
    5. Nguyen T. T. H.,
    6. Roberts M. C.
    A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44 1999 19 25
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Luna V. A.,
    2. Jernigan D. B.,
    3. Tice A.,
    4. Kellner J. D.,
    5. Roberts M. C.
    A novel multiresistant Streptococcus pneumoniae serogroup 19 clone from Washington State identified by pulsed-field gel electrophoresis and restriction fragment length patterns. J. Clin. Microbiol. 38 2000 1575 1580
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Mayer L. W.,
    2. Holmes K. K.,
    3. Falkow S.
    Characterization of plasmid deoxyribonucleic acid from Neisseria gonorrhoeae. Infect. Immun. 10 1974 712 717
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Morse S. A.,
    2. Johnson S. R.,
    3. Biddle J. W.,
    4. Roberts M. C.
    High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob. Agents Chemother. 30 1986 664 670
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    National Committee for Clinical Laboratory Standards Approved standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. NCCLS document M7-A3. 1995 National Committee for Clinical Laboratory Standards Villanova, Pa
  14. 14.↵
    1. Pickett M. J.,
    2. Hollis D. G.,
    3. Bottone E. J.
    Miscellaneous gram-negative bacteria Manual of clinical microbiology 5th ed. Balows A., et al. 1991 410 428 American Society for Microbiology Washington, D.C.
  15. 15.↵
    1. Roberts M.,
    2. Elwell L. P.,
    3. Falkow S.
    Molecular characterization of two beta-lactamase-specifying plasmids isolated from Neisseria gonorrhoeae. J. Bacteriol. 131 1977 557 563
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Roberts M. C.,
    2. Swenson C. D.,
    3. Owens L. M.,
    4. Smith A. L.
    Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 18 1980 610 615
    OpenUrlAbstract/FREE Full Text
  17. 17.
    1. Roberts M. C.,
    2. Knapp J. S.
    Host range of the conjugative 25.2-megadalton tetracycline resistance plasmid from Neisseria gonorrhoeae and related species. Antimicrob. Agents Chemother. 32 1988 488 491
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Roberts M. C.
    Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol. Rev. 19 1996 1 24
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Roberts M. C.,
    2. Chung W. O.,
    3. Roe D.,
    4. Xia M.,
    5. Marquez C.,
    6. Borthagaray G.,
    7. Whittington W. L.,
    8. Holmes K. K.
    Erythromycin-resistant Neisseria gonorrhoeae and oral commensal Neisseria spp. carry known rRNA methylase genes. Antimicrob. Agents Chemother. 43 1999 1367 1372
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Roberts M. C.,
    2. Sutcliffe J.,
    3. Courvalin P.,
    4. Jensen L. B.,
    5. Rood J.,
    6. Seppala H.
    Nomenclature for macrolide and macrolide-lincosamide-streptogramin B resistance determinants. Antimicrob. Agents Chemother. 43 1999 2823 2830
    OpenUrlFREE Full Text
  21. 21.↵
    1. Roe D. E.,
    2. Braham P. H.,
    3. Weinberg A.,
    4. Roberts M. C.
    Characterization of tetracycline resistance in Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 10 1995 227 232
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. Sambrook J.,
    2. Fritsch E. F.,
    3. Maniatis T.
    Molecular cloning: a laboratory manual 2nd ed. 1989 5.31 5.32 Cold Spring Harbor Laboratory Press Cold Spring Harbor, N.Y
  23. 23.↵
    1. Seppala H.,
    2. Nissinen A.,
    3. Yu Q.,
    4. Huovinen P.
    Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32 1993 885 891
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Shortridge V. D.,
    2. Flamm R. K.,
    3. Ramer N.,
    4. Beyer J.,
    5. Tanaka S. K.
    Novel mechanism of macrolide resistance in Streptococcus pneumoniae. Diagn. Microbiol. Infect. Dis. 26 1996 73 78
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Sutcliffe J.,
    2. Tait-Kamradt A.,
    3. Wondrack L.
    Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40 1996 1817 1824
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Sutcliffe J.,
    2. Grebe T.,
    3. Tait-Kamradt A.,
    4. Wondrack L.
    Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40 1996 2562 2566
    OpenUrlAbstract/FREE Full Text
  27. 27.
    1. Tait-Kamradt A.,
    2. Clancy J.,
    3. Cronan M.,
    4. Dib-Hajj F.,
    5. Wondrack L.,
    6. Yuan W.,
    7. Sutcliffe J.
    mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41 1997 2251 2255
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Identification of the Conjugative mefGene in Clinical Acinetobacter junii and Neisseria gonorrhoeae Isolates
Vicki A. Luna, Sydney Cousin Jr., William L. H. Whittington, Marilyn C. Roberts
Antimicrobial Agents and Chemotherapy Sep 2000, 44 (9) 2503-2506; DOI: 10.1128/AAC.44.9.2503-2506.2000

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of the Conjugative mefGene in Clinical Acinetobacter junii and Neisseria gonorrhoeae Isolates
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identification of the Conjugative mefGene in Clinical Acinetobacter junii and Neisseria gonorrhoeae Isolates
Vicki A. Luna, Sydney Cousin Jr., William L. H. Whittington, Marilyn C. Roberts
Antimicrobial Agents and Chemotherapy Sep 2000, 44 (9) 2503-2506; DOI: 10.1128/AAC.44.9.2503-2506.2000
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Acinetobacter
Conjugation, Genetic
DNA-Binding Proteins
Neisseria gonorrhoeae
transcription factors

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596